According to numerous previous studies, it has been suggested that the pathogenesis of AD may initiate with the abnormal processing of amyloid precursor protein (APP), which then leads to excessive production or decreased clearance of Aβ in the cortex2. The gene discussed is APP; the disease is Alzheimer disease.